Kjell Öberg
Researcher Next ID · RN-003659
Researcher · Medicine
Uppsala, Sweden
- Works count
- 636
- Citation count
- 41,427
- H-index
- 97
- i10-index
- 324
Research interests
Publications
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.03.304
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1607427
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1009290
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
The Lancet · 2011 · https://doi.org/10.1016/s0140-6736(11)61742-x
Gastroenteropancreatic neuroendocrine tumours
The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(07)70410-2
Current projects
No projects listed.